These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36414993)
21. Menstruation and its disorders in adolescence. Greydanus DE; McAnarney ER Curr Probl Pediatr; 1982 Aug; 12(10):1-61. PubMed ID: 6764754 [TBL] [Abstract][Full Text] [Related]
22. Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis. Maldonado LY; Sergison JE; Gao X; Hubacher D Am J Obstet Gynecol; 2020 May; 222(5):451-468.e9. PubMed ID: 31589865 [TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials. Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281 [TBL] [Abstract][Full Text] [Related]
24. Menstrual disorders in a Paediatric and Adolescent Gynaecology Clinic: patient presentations and longitudinal outcomes. Chung PW; Chan SS; Yiu KW; Lao TT; Chung TK Hong Kong Med J; 2011 Oct; 17(5):391-7. PubMed ID: 21979477 [TBL] [Abstract][Full Text] [Related]
25. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids. Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363 [TBL] [Abstract][Full Text] [Related]
27. Abnormal uterine bleeding in anticoagulated patients by drug class: outcomes and management. Brioso XB; Bolt M; Sammel MD; McKenney K Am J Obstet Gynecol; 2023 Sep; 229(3):318.e1-318.e14. PubMed ID: 37201695 [TBL] [Abstract][Full Text] [Related]
28. Current situation of menstruation and gynecological diseases prevalence among Chinese women: a cross-sectional study. Bigambo FM; Wang D; Zhang Y; Mzava SM; Dai R; Wang X BMC Womens Health; 2022 Jul; 22(1):270. PubMed ID: 35787274 [TBL] [Abstract][Full Text] [Related]
29. Menstrual disorders in the college age female. Adams Hillard PJ; Deitch HR Pediatr Clin North Am; 2005 Feb; 52(1):179-97, ix-x. PubMed ID: 15748930 [TBL] [Abstract][Full Text] [Related]
30. Menstrual Patterns and Treatment of Heavy Menstrual Bleeding in Adolescents with Bleeding Disorders. Dowlut-McElroy T; Williams KB; Carpenter SL; Strickland JL J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):499-501. PubMed ID: 26231609 [TBL] [Abstract][Full Text] [Related]
31. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308 [TBL] [Abstract][Full Text] [Related]
32. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. Chen BA; Eisenberg DL; Schreiber CA; Turok DK; Olariu AI; Creinin MD Am J Obstet Gynecol; 2020 Apr; 222(4S):S888.e1-S888.e6. PubMed ID: 31866516 [TBL] [Abstract][Full Text] [Related]
33. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders. Ray S; Ray A Cochrane Database Syst Rev; 2014 Nov; (11):CD010338. PubMed ID: 25426776 [TBL] [Abstract][Full Text] [Related]
34. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. Zimmermann A; Bernuit D; Gerlinger C; Schaefers M; Geppert K BMC Womens Health; 2012 Mar; 12():6. PubMed ID: 22448610 [TBL] [Abstract][Full Text] [Related]
35. Knowledge, attitudes, and consequences of menstrual health in urban adolescent females. Houston AM; Abraham A; Huang Z; D'Angelo LJ J Pediatr Adolesc Gynecol; 2006 Aug; 19(4):271-5. PubMed ID: 16873031 [TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women. Schütt B; Kaiser A; Schultze-Mosgau MH; Seitz C; Bell D; Koch M; Rohde B Hum Reprod; 2016 Aug; 31(8):1703-12. PubMed ID: 27288475 [TBL] [Abstract][Full Text] [Related]
37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
38. A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data. Kazemijaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Khalili D; Hosseinpanah F; Azizi F Arch Iran Med; 2017 Sep; 20(9):558-563. PubMed ID: 29048917 [TBL] [Abstract][Full Text] [Related]
39. Abnormal Uterine Bleeding Among COVID-19 Vaccinated and Recovered Women: a National Survey. Issakov G; Tzur Y; Friedman T; Tzur T Reprod Sci; 2023 Feb; 30(2):713-721. PubMed ID: 35986194 [TBL] [Abstract][Full Text] [Related]